ICAM1 and neoplasm: Moreover, the combination treatment led to a significantly increased expression level of ICAM1 on tumor cells, which was also observed in the palbociclib group (Fig. 7f), but palbociclib did not induce ICAM1 expression on immune cells (Supplementary Fig. 19D, E).